DJIA 17,828.24 0.49 0.00%
NASDAQ 4,791.63 4.31 0.09%
S&P 500 2,067.56 -5.27 -0.25%
market minute promo

Alnylam Pharmaceuticals (NASDAQ: ALNY)

100.55 -0.18 (-0.18%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALNY $100.55 -0.18%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $101.15
Previous Close $100.73
Daily Range $100.25 - $103.36
52-Week Range $47.03 - $112.57
Market Cap $7.7B
P/E Ratio -19.60
Dividend (Yield) $0.00 (0.0%)
Volume 211,430
Average Daily Volume 672,878
Current FY EPS -$5.26

Sector

Healthcare

Industry

Drugs

Alnylam Pharmaceuticals (ALNY) Description

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes. Website: http://www.alnylam.com/

News & Commentary Rss Feed

Isis Pharmaceuticals Inc. Strikes Out on Its Own

Isis Pharmaceuticals uses its third-quarter earnings call to announce a reorganization as it pushes into late-stage development on its own.

December's Essential, Stock-Moving Biotech Events Explained While Eating Turkey

Marina Biotech: A Forgotten And Grossly Undervalued Game-Changer

Regulus To See Further Declines

Cramer's Lightning Round - Mobileye Will Have A Good Quarter (11/17/14)

'Mad Money' Lightning Round: I'm Buy, Buy, Buying Biogen

Alnylam Reports Positive Initial Phase II Data on Revusiran - Analyst Blog

Alnylam Pharmaceuticals (ALNY) Weak On High Volume

Alnylam Adds Hepatic Infectious Disease Drugs to Pipeline - Analyst Blog

Alnylam Adds Hepatic Infectious Disease Drugs to Pipeline - Analyst Blog

Alnylam Expands Hepatic Infectious Disease Pipeline; Adds ALN-HDV For The Treatment Of Chronic Hepat

Alnylam Expands Hepatic Infectious Disease Pipeline; Adds ALN-HDV For The Treatment Of Chronic Hepatitis Delta Virus Infection And ALN-PDL For The Treatment Of Chronic Liver Infections

See More ALNY News...

ALNY's Top Competitors

ALNY $100.55 (-0.18%)
Current stock: ALNY
AMGN $165.31 (0.36%)
Current stock: AMGN
GILD $100.20 (-0.10%)
Current stock: GILD
BIIB $307.62 (0.89%)
Current stock: BIIB